<VariationArchive VariationID="4536" VariationName="NM_001122955.4(BSCL2):c.517dup (p.Thr173fs)" VariationType="Duplication" Accession="VCV000004536" Version="11" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-03-05" DateCreated="2015-05-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19575" VariationID="4536">
      <GeneList>
        <Gene Symbol="BSCL2" FullName="BSCL2 lipid droplet biogenesis associated, seipin" GeneID="26580" HGNC_ID="HGNC:15832" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62690262" stop="62709537" display_start="62690262" display_stop="62709537" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62457733" stop="62477090" display_start="62457733" display_stop="62477090" Strand="-" />
          </Location>
          <OMIM>606158</OMIM>
        </Gene>
        <Gene Symbol="HNRNPUL2-BSCL2" FullName="HNRNPUL2-BSCL2 readthrough (NMD candidate)" GeneID="100534595" HGNC_ID="HGNC:49189" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62690262" stop="62727384" display_start="62690262" display_stop="62727384" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001122955.4(BSCL2):c.517dup (p.Thr173fs)</Name>
      <CanonicalSPDI>NC_000011.10:62694680:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="62694680" stop="62694681" display_start="62694680" display_stop="62694681" variantLength="1" positionVCF="62694680" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="62462152" stop="62462153" display_start="62462152" display_stop="62462153" variantLength="1" positionVCF="62462152" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>T109fs</ProteinChange>
      <ProteinChange>T173fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386027.1" sequenceAccession="NM_001386027" sequenceVersion="1" change="c.517dup">
            <Expression>NM_001386027.1:c.517dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372956.1" sequenceAccession="NP_001372956" sequenceVersion="1" change="p.Thr173fs">
            <Expression>NP_001372956.1:p.Thr173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386028.1" sequenceAccession="NM_001386028" sequenceVersion="1" change="c.517dup">
            <Expression>NM_001386028.1:c.517dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001372957.1" sequenceAccession="NP_001372957" sequenceVersion="1" change="p.Thr173fs">
            <Expression>NP_001372957.1:p.Thr173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032667.6" sequenceAccession="NM_032667" sequenceVersion="6" change="c.325dup">
            <Expression>NM_032667.6:c.325dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116056.3" sequenceAccession="NP_116056" sequenceVersion="3" change="p.Thr109fs">
            <Expression>NP_116056.3:p.Thr109fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.62694681dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.62694681dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.62462153dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.62462153dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008461.1" sequenceAccession="NG_008461" sequenceVersion="1" change="g.19894dup">
            <Expression>NG_008461.1:g.19894dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033077.1" sequenceAccession="NG_033077" sequenceVersion="1" change="g.219dup">
            <Expression>NG_033077.1:g.219dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037946.1" sequenceAccession="NR_037946" sequenceVersion="1" change="n.3037dup">
            <Expression>NR_037946.1:n.3037dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122955.4" sequenceAccession="NM_001122955" sequenceVersion="4" change="c.517dup" MANESelect="true">
            <Expression>NM_001122955.4:c.517dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116427.1" sequenceAccession="NP_001116427" sequenceVersion="1" change="p.Thr173fs">
            <Expression>NP_001116427.1:p.Thr173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001130702.2" sequenceAccession="NM_001130702" sequenceVersion="2" change="c.325dup">
            <Expression>NM_001130702.2:c.325dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001124174.2" sequenceAccession="NP_001124174" sequenceVersion="2" change="p.Thr109fs">
            <Expression>NP_001124174.2:p.Thr109fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032667.6" sequenceAccession="NM_032667" sequenceVersion="6" change="c.325dupA">
            <Expression>NM_032667.6:c.325dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_235" sequenceAccession="LRG_235">
            <Expression>LRG_235:g.19894dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_235t2" sequenceAccession="LRG_235t2">
            <Expression>LRG_235t2:c.325dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_235p2" sequenceAccession="LRG_235p2" change="p.Thr109fs">
            <Expression>LRG_235p2:p.Thr109fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277921" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606158.0006" DB="OMIM" />
        <XRef Type="rs" ID="786205071" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.517dup (p.Thr173fs) AND Congenital generalized lipodystrophy type 2" Accession="RCV000004794" Version="9">
        <ClassifiedConditionList TraitSetID="1248">
          <ClassifiedCondition DB="MedGen" ID="C1720863">Congenital generalized lipodystrophy type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.517dup (p.Thr173fs) AND multiple conditions" Accession="RCV002496260" Version="1">
        <ClassifiedConditionList TraitSetID="79036">
          <ClassifiedCondition DB="MedGen" ID="C1720863">Congenital generalized lipodystrophy type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2931276">Hereditary spastic paraplegia 17</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5436838">Neuronopathy, distal hereditary motor, type 5C</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4014700">Severe neurodegenerative syndrome with lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.517dup (p.Thr173fs) AND Berardinelli-Seip congenital lipodystrophy" Accession="RCV003311639" Version="1">
        <ClassifiedConditionList TraitSetID="50960">
          <ClassifiedCondition DB="MedGen" ID="CN262437">Berardinelli-Seip congenital lipodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-01-06" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001122955.4(BSCL2):c.517dup (p.Thr173fs) AND Charcot-Marie-Tooth disease type 2" Accession="RCV002512772" Version="2">
        <ClassifiedConditionList TraitSetID="12238">
          <ClassifiedCondition DB="MedGen" ID="C0270914">Charcot-Marie-Tooth disease type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-20" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-05-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11479539</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12030893</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15181077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17535271</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23564749</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301391</ID>
          <ID Source="BookShelf">NBK1212</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="50960" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="42980" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Berardinelli-Seip congenital lipodystrophy</ElementValue>
                <XRef ID="GPDx_BSCL_BSCL2_001" DB="GenePathDx, GenePath diagnostics" />
                <XRef ID="MONDO:0018883" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BSCL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13388" />
                <XRef ID="13388" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="CN262437" DB="MedGen" />
              <XRef ID="MONDO:0018883" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79036" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="2558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SEIP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 2</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+2/1830" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010020" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BERARDINELLI SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, BSCL2-RELATED</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CGL2</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10212" />
                <XRef ID="10212" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720863" DB="MedGen" />
              <XRef ID="MONDO:0010020" DB="MONDO" />
              <XRef Type="MIM" ID="269700" DB="OMIM" />
            </Trait>
            <Trait ID="54804" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neuronopathy, distal hereditary motor, type 5C</ElementValue>
                <XRef ID="MONDO:0030860" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 13</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606158.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606158.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606158.0020" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURONOPATHY, DISTAL HEREDITARY MOTOR, HARDING TYPE VC</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEUROPATHY, DISTAL HEREDITARY MOTOR, HARDING TYPE VC</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPINAL MUSCULAR ATROPHY, DISTAL, HARDING TYPE VC</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DHMN VC</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DSMAVC</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HMND13</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DHMN5C</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HMN5C</ElementValue>
                <XRef Type="MIM" ID="619112" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18268" />
                <XRef ID="18268" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5436838" DB="MedGen" />
              <XRef ID="MONDO:0030860" DB="MONDO" />
              <XRef Type="MIM" ID="619112" DB="OMIM" />
            </Trait>
            <Trait ID="21315" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Severe neurodegenerative syndrome with lipodystrophy</ElementValue>
                <XRef ID="MONDO:0014402" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, progressive, with or without lipodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ENCEPHALOPATHY, PROGRESSIVE, WITH LIPODYSTROPHY</ElementValue>
                <XRef Type="Allelic variant" ID="606158.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606158.0018" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PELD</ElementValue>
                <XRef Type="MIM" ID="615924" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17552" />
                <XRef ID="17552" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of BSCL2-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and pes cavus and other foot deformities. Disease severity is variable among and within families.</Attribute>
                <XRef ID="NBK1307" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301484</ID>
                <ID Source="BookShelf">NBK1307</ID>
              </Citation>
              <XRef ID="363400" DB="Orphanet" />
              <XRef ID="C4014700" DB="MedGen" />
              <XRef ID="MONDO:0014402" DB="MONDO" />
              <XRef Type="MIM" ID="615924" DB="OMIM" />
            </Trait>
            <Trait ID="10081" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 17</ElementValue>
                <XRef ID="MONDO:0010043" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Silver spastic paraplegia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 17</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia with amyotrophy of hands and feet</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal dominant spastic paraplegia type 17</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPG17</ElementValue>
                <XRef Type="MIM" ID="270685" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of BSCL2-related neurologic disorders includes Silver syndrome and variants of Charcot-Marie-Tooth neuropathy type 2, distal hereditary motor neuropathy (dHMN) type V, and spastic paraplegia 17. Features of these disorders include onset of symptoms ranging from the first to the seventh decade, slow disease progression, upper motor neuron involvement (gait disturbance with pyramidal signs ranging from mild to severe spasticity with hyperreflexia in the lower limbs and variable extensor plantar responses), lower motor neuron involvement (amyotrophy of the peroneal muscles and small muscles of the hand), and pes cavus and other foot deformities. Disease severity is variable among and within families.</Attribute>
                <XRef ID="NBK1307" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">BSCL2-Related Neurologic Disorders/Seipinopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4219" />
                <XRef ID="4219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301484</ID>
                <ID Source="BookShelf">NBK1307</ID>
              </Citation>
              <XRef ID="100998" DB="Orphanet" />
              <XRef ID="C2931276" DB="MedGen" />
              <XRef ID="MONDO:0010043" DB="MONDO" />
              <XRef Type="MIM" ID="270685" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12238" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9467" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth, Type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease type 2</ElementValue>
                <XRef ID="MONDO:0018993" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12431" />
                <XRef ID="12431" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301532</ID>
                <ID Source="BookShelf">NBK1358</ID>
              </Citation>
              <XRef ID="64746" DB="Orphanet" />
              <XRef ID="C0270914" DB="MedGen" />
              <XRef ID="MONDO:0018993" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1248" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SEIP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 2</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+2/1830" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010020" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BERARDINELLI SYNDROME</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, BSCL2-RELATED</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CGL2</ElementValue>
                <XRef Type="MIM" ID="269700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10212" />
                <XRef ID="10212" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720863" DB="MedGen" />
              <XRef ID="MONDO:0010020" DB="MONDO" />
              <XRef Type="MIM" ID="269700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5463071" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_032667.6:c.325dup|OMIM:269700;270685;615924;619112" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002806083" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032667.6:c.325dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="269700" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270685" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615924" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619112" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7508477" SubmissionDate="2023-06-02" DateLastUpdated="2023-07-16" DateCreated="2023-07-16">
        <ClinVarSubmissionID localKey="NM_032667.6:c.325dupA|Orphanet:528" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004011974" DateUpdated="2023-07-16" DateCreated="2023-07-16" Type="SCV" Version="1" SubmitterName="Inherited Neuropathy Consortium Ii, University Of Miami" OrgID="508951" OrganizationCategory="consortium" OrgAbbreviation="Lab-SZU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11479539</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032667.6:c.325dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA528" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13361505</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24970" SubmissionDate="2020-12-17" DateLastUpdated="2023-10-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606158.0006_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" title="BSCL2, 1-BP INS, 669A_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" />
        <ClinVarAccession Accession="SCV000024970" DateUpdated="2023-10-21" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 South African Portuguese families with Berardinelli-Seip congenital lipodystrophy (CGL2; 269700), Magre et al. (2001) found homozygosity for a frameshift resulting from insertion of an adenine at nucleotide 669 of the BSCL2 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">11479539</ID>
              </Citation>
              <XRef DB="OMIM" ID="269700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Bhayana et al. (2002) described the same mutation in a 10-year-old girl from Canada whose parents were not known to be consanguineous, although they came from the same region of Portugal. The family history was positive for BSCL on both sides of the family. Her father had 2 affected male cousins who were born to consanguineous parents and died in childhood. Another affected female first cousin of the father died at 30 years of age with renal failure. An affected male, the second cousin of the patient's mother, died at 28 years of age. In addition to having the typical attributes of complete lipodystrophy, the patient had been diagnosed with hypertrophic cardiomyopathy in the first year of life. A relationship between congenital lipodystrophy syndromes and cardiac disorders is suggested by the fact that mutations in lamin A/C (LMNA; 150330) cause either lipodystrophy or cardiomyopathy.</Attribute>
              <Citation>
                <ID Source="PubMed">12030893</ID>
              </Citation>
              <XRef DB="OMIM" ID="150330" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Fu et al. (2004) found this mutation in 18 patients from 15 Caucasian families from the same region of Serido county of Rio Grande do Norte State in northeastern Brazil.</Attribute>
              <Citation>
                <ID Source="PubMed">15181077</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <Name>BSCL2, 1-BP INS, 669A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 669A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606158.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5712520" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="1141182|MedGen:CN043576" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003026535" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11479539</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23564749</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11479539</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17535271</ID>
          </Citation>
          <Comment>This variant is present in population databases (rs786205071, gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr109Asnfs*5) in the BSCL2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BSCL2 are known to be pathogenic (PMID: 11479539, 23564749). This premature translational stop signal has been observed in individuals with autosomal recessive Berardinelli-Seip congenital lipodystrophy (PMID: 11479539, 17535271). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 4536). This variant is also known as c.669insA .</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.62462152_62462153insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043576" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2244141" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000011.9:g.62462152_62462153insT|OMIM:269700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001138338" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.62462152_62462153insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="269700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="957410" SubmissionDate="2016-12-08" DateLastUpdated="2022-10-01" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="NM_032667.5:c.325dupA|OMIM:269700" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000490133" DateUpdated="2022-10-01" DateCreated="2015-10-11" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1212</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BSCL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_116056.3:p.Thr109AsnfsTer5</Name>
            <Name>c.324_325insA</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032667.5:c.325dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720863" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2244141" TraitType="Disease" MappingType="XRef" MappingValue="269700" MappingRef="OMIM">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463071" TraitType="Disease" MappingType="XRef" MappingValue="270685" MappingRef="OMIM">
        <MedGen CUI="C2931276" Name="Hereditary spastic paraplegia 17" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463071" TraitType="Disease" MappingType="XRef" MappingValue="269700" MappingRef="OMIM">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="957410" TraitType="Disease" MappingType="XRef" MappingValue="C1720863" MappingRef="MedGen">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7508477" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA528" MappingRef="Orphanet">
        <MedGen CUI="CN262437" Name="Berardinelli-Seip congenital lipodystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463071" TraitType="Disease" MappingType="XRef" MappingValue="619112" MappingRef="OMIM">
        <MedGen CUI="C5436838" Name="Neuronopathy, distal hereditary motor, type 5C" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24970" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2" MappingRef="Preferred">
        <MedGen CUI="C1720863" Name="Congenital generalized lipodystrophy type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463071" TraitType="Disease" MappingType="XRef" MappingValue="615924" MappingRef="OMIM">
        <MedGen CUI="C4014700" Name="Severe neurodegenerative syndrome with lipodystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5712520" TraitType="Disease" MappingType="XRef" MappingValue="CN043576" MappingRef="MedGen">
        <MedGen CUI="C0270914" Name="Charcot-Marie-Tooth disease type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

